株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

乳房インプラントの世界市場

Global Breast Implant Market - 2018 - 2025

発行 DataM Intelligence 商品コード 760532
出版日 ページ情報 英文 130-180 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=108.55円で換算しております。
Back to Top
乳房インプラントの世界市場 Global Breast Implant Market - 2018 - 2025
出版日: 2018年12月01日 ページ情報: 英文 130-180 Pages
概要

当レポートでは、世界の乳房インプラント市場について調査分析し、産業分析、市場分析、地域別分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 世界の乳房インプラント市場:調査範囲・手法

第2章 世界の乳房インプラント市場:主要動向と発展

  • 主要動向と発展

第3章 産業分析

  • 促進要因
  • 抑制要因
  • 規制シナリオ
  • ファイブフォース分析

第4章 世界の乳房インプラント市場区分

  • 製品の種類別
    • シリコーン乳房インプラント
    • 生理食塩水乳房インプラント
  • 用途別
    • 再建手術
    • 美容整形
  • エンドユーザー別
    • 病院
    • 美容外科クリニック
    • その他

第5章 世界の乳房インプラント市場:地域別

  • 地域の概要
  • 北米
  • 欧州
  • 南米
  • アジア太平洋地域
  • その他

第6章 競合情勢

  • 競合シナリオ
  • メーカーの主要戦略
  • 製品ベンチマーキング

第7章 企業プロファイル

  • Allergan Plc
  • Mentor Worldwide LLC (Johnson & Johnson)
  • Sientra Inc.
  • GC Aesthetics PLC
  • POLYTECH Health & Aesthetics GmbH
  • Hansbiomed Co. Ltd.
  • Ideal Implant Incorporated
  • Guangzhou Wanhe Plastic Materials Co., Ltd.
  • Establishment Labs S.A.
  • Groupe Sebbin SAS

第8章 付録

目次

Breast implants are the medical devices which are implanted under the breast tissue or under the chest muscle to increase the breast size (augmentation) or to rebuild breast tissue after mastectomy or other damage to the breast (reconstruction).

The FDA has approved implants for increasing breast size in women (augmentation), for reconstruction after breast cancer surgery, and to correct the developmental defects. Implants are also approved to correct or improve the result of previous surgery.

The FDA has approved two types of breast implants for sale in the United States: saline (salt water solution)-filled and silicone gel-filled. Both have a silicone outer shell and vary in size, shell thickness, and shape.

The global breast implant market is expected to grow at a CAGR of XX% to reach market value of USD XXXX million by 2025.

Global Breast Implant Market 2016-2025, in USD Million

2016 14,362

2017 15,242

2018 16,274

2025 27,650

Market Drivers:

Increase in beauty consciousness and breast cancer has driven the global breast implant market.

In 2015, nearly 280,000 women and teenagers underwent surgery to have their breasts enlarged with silicone or saline implants, and about 106,000 breast cancer patients had reconstruction after mastectomy, often with implants.

Breast augmentation is the number one cosmetic surgery in the U.S., with over 290,000 procedures completed in 2016

Market Restraints:

The breast implant has various side-effects, such as implant rupture, wrinkling, bleeding, asymmetry, anesthesia reaction, scarring, pain, and infection. These complications occur in at least 1% of breast implant patients

Up to 20% of women who decide to have breast implant surgery have them removed within 8 to 10 years.

Due to such side effects, the global breast implant market is expected to be hampered over the forecast period.

Market Segmentation

By product type

The silicone breast implant segment dominates the global breast implant market. Most of the breast augment procedures performed worldwide comprised of silicone breast implants.

Increasing cases of cancer and mastectomy will increase the demand for silicone breast implants in the future, since they have less chance of visible wrinkling or rippling, making them an improved choice for post-mastectomy breast reconstruction.

The launch of highly cohesive silicone gel breast implants has reduced the complication of rupturing, a major complication associated with the breast implant procedure.

By geography

North America dominates the global breast implant market in 2017.Increasing breast cancer cases in the U.S. is expected to boost the North America breast implant market over the forecast period -

For instance, in 2018, an estimated 266,120 new cases of invasive breast cancer are expected to be diagnosed in women in the U.S., along with 63,960 new cases of non-invasive breast cancer.

Breast augmentation and breast reconstruction are the most popular surgical procedures in North America. The U.S. holds the major share in North America region.

The FDA approved saline-filled breast implants for women aged 18 years. Only three companies have FDA approval to market saline implants in the US. Allergan and Mentor received FDA approval in 2000, and Ideal Implant received FDA approval in November 2014.

Market share of Global Breast Implant Market by Region, 2017

North America 38.32%

Asia Pacific 27.71%

Europe 23.03%

South America 6.24%

ROW 4.70%

Competitive Landscape

The increase in approvals by FDA on the manufacturing of breast implant products is driving the global breast implant market.

In April 2018, Ideal Implant Incorporated announced that they have received FDA approval to manufacture their Structured Breast Implant at Vesta, a Lubrizol LifeSciences company of silicone products and other medical devices.

In April 2018, Sientra, Inc. have announced that Food and Drug Administration (FDA) have approved the Company's PMA supplement allowing commercialization of its OPUS-branded breast implant products manufactured by Vesta, a Lubrizol LifeSciences company, at Vesta's Wisconsin-based manufacturing facility.

In April 2017, Mentor Worldwide LLC, a global leader in breast aesthetics, has announced that it has received approval from the U.S. Food & Drug Administration (FDA) to market MemoryGel® Xtra silicone gel-filled breast implants in the U.S.

In January 2017, Allergan plc has announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market NATRELLE INSPIRA® SoftTouch breast implants, offering women undergoing breast reconstruction, augmentation or revision surgery a new medium firmness gel, or cohesive, implant option.

Why purchase the report?

  • Visualize the composition of the Breast Implant Market across each indication, in terms of product type, by application, and by end-user highlighting the key commercial assets and players.
  • Identify commercial opportunities in Breast Implant Market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of the Breast Implant Market - level 4/5 segmentation
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study
  • Product mapping in excel for the Breast Implant products of all major market players

Target Audience

  • Raw Material Suppliers/ Buyers
  • Product Suppliers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturer

Table of Contents

1. GLOBAL BREAST IMPLANT MARKET-SCOPE AND METHODOLOGY

  • 1.1. Research Methodology
  • 1.2. Scope of the market

2. GLOBAL BREAST IMPLANT MARKET - KEY TRENDS AND DEVELOPMENTS

  • 2.1. Key Trends and Developments

3. INDUSTRY ANALYSIS

  • 3.1. Drivers
  • 3.2. Restraints
  • 3.3. Regulatory Scenario
  • 3.4. Porter's Five Forces Analysis

4. GLOBAL BREAST IMPLANT MARKET SEGMENTATION

  • 4.1. BY PRODUCT TYPE
    • 4.1.1. Silicone Breast Implants
    • 4.1.2. Saline Breast Implants
  • 4.2. BY APPLICATION
    • 4.2.1. Reconstructive Surgery
    • 4.2.2. Cosmetic Surgery
  • 4.3. BY END-USER
    • 4.3.1. Hospitals
    • 4.3.2. Cosmetology Clinics
    • 4.3.3. Others

5. GLOBAL BREAST IMPLANT MARKET - BY GEOGRAPHY

  • 5.1. Geographic Overview
  • 5.2. North America
    • 5.2.1. U.S.
    • 5.2.2. Canada
    • 5.2.3. Mexico
  • 5.3. Europe
    • 5.3.1. Germany
    • 5.3.2. U.K.
    • 5.3.3. France
    • 5.3.4. Rest of Europe
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
    • 5.4.3. Rest of South America
  • 5.5. Asia Pacific
    • 5.5.1. China
    • 5.5.2. India
    • 5.5.3. Japan
    • 5.5.4. Australia
    • 5.5.5. Rest of Asia Pacific
  • 5.6. Rest of World

6. COMPETITIVE LANDSCAPE

  • 6.1. Competitive Scenario
  • 6.2. Key Strategies adopted by Manufacturers
  • 6.3. Product Benchmarking

7. COMPANY PROFILES

  • 7.1. Allergan Plc
  • 7.2. Mentor Worldwide LLC (Johnson & Johnson)
  • 7.3. Sientra Inc.
  • 7.4. GC Aesthetics PLC
  • 7.5. POLYTECH Health & Aesthetics GmbH
  • 7.6. Hansbiomed Co. Ltd.
  • 7.7. Ideal Implant Incorporated
  • 7.8. Guangzhou Wanhe Plastic Materials Co., Ltd.
  • 7.9. Establishment Labs S.A.
  • 7.10. Groupe Sebbin SAS

8. APPENDIX

  • 8.1. Sources
  • 8.2. List of Tables
  • 8.3. Expert Panel Validation
  • 8.4. Disclaimer
  • 8.5. Contact Us
Back to Top